Who makes Adamgammadex Sodium?

Adamgammadex Sodium is developed by Amckaus PTY LTD..

What development phase is Adamgammadex Sodium in?

Adamgammadex Sodium is in Phase 1.

Last reviewed 2026-04-23 · How we verify

Adamgammadex Sodium

Amckaus PTY LTD. · Phase 1 active Small molecule

At a glance

Generic name	Adamgammadex Sodium
Also known as	Aom0319
Sponsor	Amckaus PTY LTD.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Aom0319 SAD Study in Healthy Subjects (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Adamgammadex Sodium CI brief — competitive landscape report
Adamgammadex Sodium updates RSS · CI watch RSS
Amckaus PTY LTD. portfolio CI